Vertex Pharmaceuticals (VRTX, $445.21) was one of the top gainers for the month, rising +1 to $445.21 per share. A.I.dvisor analyzed 903 stocks in the Biotechnology Industry for the month ending May 17, 2024 and discovered that of them (6) exhibited an Uptrend while of them (3) exhibited a Downtrend.